Mason & Associates Inc Buys New Shares in Oscar Health, Inc. $OSCR

Mason & Associates Inc purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 38,128 shares of the company’s stock, valued at approximately $722,000.

Other hedge funds have also modified their holdings of the company. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. American Century Companies Inc. increased its holdings in Oscar Health by 45.4% in the 2nd quarter. American Century Companies Inc. now owns 2,802,649 shares of the company’s stock worth $60,089,000 after buying an additional 875,388 shares during the period. State of Michigan Retirement System purchased a new position in Oscar Health during the 3rd quarter worth approximately $27,448,000. Jump Financial LLC raised its position in Oscar Health by 798.3% during the 2nd quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock worth $30,906,000 after buying an additional 1,281,032 shares during the last quarter. Finally, Bienville Capital Management LLC acquired a new stake in Oscar Health during the 2nd quarter valued at approximately $21,204,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Barclays set a $18.00 price objective on shares of Oscar Health and gave the stock an “equal weight” rating in a research note on Monday, January 5th. Stephens began coverage on Oscar Health in a research report on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price target on the stock. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a research note on Thursday. Finally, UBS Group reiterated a “neutral” rating and set a $15.00 price target on shares of Oscar Health in a research report on Wednesday. Two investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $16.88.

Insiders Place Their Bets

In other news, insider Mario Schlosser sold 76,962 shares of the stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $17.01, for a total transaction of $1,309,123.62. Following the transaction, the insider owned 350,180 shares in the company, valued at $5,956,561.80. This trade represents a 18.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Richard Scott Blackley sold 25,135 shares of the business’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $416,989.65. Following the completion of the sale, the chief financial officer directly owned 1,351,034 shares of the company’s stock, valued at approximately $22,413,654.06. The trade was a 1.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 197,125 shares of company stock worth $3,265,300. Corporate insiders own 24.39% of the company’s stock.

Oscar Health Trading Down 2.2%

OSCR stock opened at $13.41 on Friday. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.80. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm has a market cap of $3.55 billion, a P/E ratio of -7.70 and a beta of 1.90. The company’s 50-day simple moving average is $15.24 and its 200-day simple moving average is $16.69.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 37.72% and a negative net margin of 3.79%.The business had revenue of $2.76 billion during the quarter, compared to analyst estimates of $3.12 billion. During the same period in the previous year, the company posted ($0.62) EPS. The business’s revenue for the quarter was up 17.3% compared to the same quarter last year. As a group, equities analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.